After confirming the growth-inhibiting effect of our suicide gene approach on human DLBCL cells in vitro, we further assessed whether the tk-VLP treatment is similarly effective in vivo and thus potentially therapeutically useful. Here, TKT is linked to diffuse large B-cell lymphoma.